Introduction
Vanishing white matter disease (VWM) is an autosomal recessive disease with symptoms including spastic paraparesis, cerebellar symptoms and gait ataxia. 1, 2 Besides pediatric VWM, late adult-onset VWM cases have been reported up to the age of 60 over recent years. 3, 4 Three different courses in adultonset VWM have been suggested: (1) primary clinical progression, (2) dramatic secondary clinical deterioration after stress-related events and (3) stable clinical course for decades. 5 So far, no specific treatment for VWM is known. Magnetic resonance (MR) imaging in VWM shows distinct changes with extensive whitematter hyperintensities (WMH) in T2-weighted fluidattenuated-inversion-recovery (FLAIR) sequences. 2, [4] [5] [6] Often, these early changes are followed by the ''vanishing'' aspect of VWM with areas of cystic degeneration that usually show cerebrospinal fluid (CSF)-like signal intensities on magnetic resonance imaging (MRI). 5, 7 To our knowledge, volumetric follow-up studies on MRI in patients with adult-onset VWM are lacking. Since precise manual quantification of cystic degeneration is technically challenging, very time consuming and prone to bias, automated segmentation of WMH might be helpful to quantify disease activity. Here, we implemented the recently proposed method of extreme value distribution (EVD)-based segmentation to automatically quantify WMH in adult-onset VWM.
Methods

Participants
One female patient (mid-forties) with a three-year medical history of adult-onset VWM presented with slowly progressive intention tremor and gait ataxia. Genetic analysis confirmed a homozygous point mutation c.260C > T (p.Ala87Val) in the EIF2B3 gene. 4 The patient was interviewed and clinically examined at the local Department of Neurology on initial presentation (September 2013) and one year later. A standardized scale was used to evaluate cerebellar dysfunction (International Cooperative Ataxia Rating Scale (ICARS) 8 ). Informed consent for scientific evaluation of material was given at the time of admission.
As a control group, five individuals (three females, 51 years AE 10.1) with relapsing-remitting multiple sclerosis (MS) were included. All participants in the control group were clinically stable under medical treatment, had a high T2-hyperintense lesion load and at least two MR follow-ups without any new T2-hyperintense lesions within one year, as confirmed by two experienced neuroradiologists.
MRI
MRI was acquired on a 3T MRI scanner (Achieva 3T, Philips Medical Systems, The Netherlands), using an 8-channel or 16-channel phased-array head coil between November 2014 and April 2016. The same high-resolution FLAIR sequence aligned parallel to the anterior/posterior commissure was acquired both for initial and follow-up MRI (VWM patient: 1.11 Â 1.11 Â 1.12 mm, repetition time (TR)/ echo time (TE) of 4,800/275 ms; control group: 0.90 Â 0.90 Â 1.5 mm, TR/TE of 10,000/140 ms) in the course of one year.
Image preprocessing
The de-identified three-dimensional (3D)-FLAIR sequences of all participants were exported from our picture archiving and communication system (PACS) to a local hard disc. Common preprocessing steps were performed using open-source tools of the Insight Segmentation and Registration Toolkit (ITK 9 ). First, local field inhomogeneities in the MR images were corrected (ITK N4 Bias Field Correction 10 ). Second, the skull was removed from the image (ITK skull-stripping 11 ) and third, CSF was extracted from the image using an Otsu filter (ITK OtsuFilter 12 ). All image preprocessing steps were implemented in a Python environment (Python Software Foundation, version 2.7, Figure 1 ).
WMH segmentation
WMH were quantified based on a method recently published by Wang et al. 13 In this method, intensity histograms of FLAIR sequences are processed and WMH are modeled by an EVD. The segmentation algorithm itself calculates a Gaussian distribution, which models gray-and white-matter intensities as well as an EVD, which models WMH. Since the EVD is calculated relatively to the Gaussian distribution, the algorithm can be easily applied to images with different intensity distributions, as is the case for sequences acquired with different head coils or different TR/TE parameters. The EVD was implemented as a ''Fre´chet'' distribution because it was shown to outperform other EVDs in case of high amounts of WMH like in VWM. To obtain the final segmentation from the EVD-based WMH segmentation, we used a similar postprocessing step as suggested by Wang et al., including opening and closing functions with a 3 Â 3 kernel. 13 WMH segmentation and postprocessing were also implemented in a Python environment.
Statistical analysis
Wilcoxon signed rank test was applied to detect differences between initial and follow-up WMH volume with p < 0.05 regarded as significant. Volume is displayed as cubic centimeters (cm 3 ) and, if available, the corresponding standard error of the mean (SEM) is shown The Neuroradiology Journal 30 (1) in brackets. Coefficient of variation (CoV) was computed as quotient of standard deviation (SD) and arithmetic mean of the WMH segmentations of the control group. The corresponding root-mean-square error (RMSE) for precision accuracy was calculated as follows: 14 
Multiplying the RMSE by 2.77 shows the least significant change (LSC), which is the minimal change of WMH volume that can be considered significant. 15 Statistics were calculated with IBM SPSS Statistics, release 23.0 (IBM, Armonk, NY, USA) and Excel 2010 (Microsoft, Redmond, WA, USA).
Results
Over the course of one year the symptoms of the patient remained stable and no stress-related events occurred (ICARS: 21/100 at initial presentation; 21/ 100 at one-year follow-up; Figure 2(a) ). Initial MRI showed typical VWM-related changes with extensive bihemispherical WMH on FLAIR and neighboring cystic degeneration as previously described. 4 Followup MRI in the course of one year did not reveal a detectable increase of the cystic degeneration, cerebral atrophy or the bihemispheric WMH in the visual exploration by two experienced neuroradiologists (Figure 2(b) ). Considering the fact that extensive WMH could mask changes in lesion load, we then quantified WMH by automated segmentation. The segmentation revealed a progression of WMH volume from 44.04 cm 3 to 46.61 cm 3 in the VWM patient, yielding a volumetric increase of 2.7 cm 3 (5.84%) in the course of one year (Figure 3 ). In the control group no significant volume change (-1.16% AE 1.15; p ¼ 0.345) could be detected (initial WMH volume: 65.37 cm 3 AE 4.84; follow-up: 64.52 cm 3 AE 4.51). The RMSE (1.85%) and the LSC (5.13%) in the control group were lower than the WMH increase in the VWM patient, supporting a true increase of WMH volume instead of measurement failure. 
Discussion
Over the last decade it has become obvious that patients with diagnosed adult-onset VWM show a large variation of the phenotype and course of the disease. Our patient seemed to be clinically stable over the course of one year but EVD-based automated volumetry revealed a progression of WMH. Considering that progression of VWM is mainly quantified by clinical scores or semi-quantitative MRI rating scales, 16 we hypothesize that MRI volumetry could be a more objective and accurate additional diagnostic tool.
Our results indicate that even in VWM patients with stable clinical course there could be a silent radiographic progression.
Changes of WMH could be influenced by confounding factors. Since all MR scans were performed on the same 3T-scanner with the same high-resolution 3D-FLAIR sequences corrected for local magnetic inhomogeneities, the data acquisition is highly comparable. A high intraclass correlation of 0.993 (Pearson's correlation coefficient 0.996) between EVD-based segmentation (Fre´chet) and the current gold standard of manual segmentation supports the reliability of EVDbased segmentation. 13 Wang et al. 13 proposed two different distribution models of the EVD: the Gumbel and the Fre´chet model. They reported that Fre´chet's distribution of EVD was superior in cases with severe WMH volume, which underlines our results. In contrast to the increase of WMH in the clinically stable VWM patient, the control group of stable MS patients showed no significant changes in WMH. Together with the low precision error, this supports our results of a true volumetric increase of WMH in the VWM patient.
Certainly our study has several limitations. First, as the late adult-onset form of VWM is a rare disorder with only a few cases described worldwide, further patients could not be included in the study. Although identical data acquisition and preprocessing as well as comparison to a control cohort indicate a true increase of WMH in the clinically stable VWM patient, we cannot rule out measurement variability completely. Second, a commonly used scoring system like ICARS might not be sensitive enough to detect very slow deterioration of clinical symptoms. Pathophysiologically it is not plausible that a neurodegenerative leukodystrophic disease such as VWM should be stable for years, but rather show a relatively small progression. Therefore, a slight clinical progression might have occurred, but could not be quantified by ICARS. Third, typical MRI findings in VWM might represent different neuropathological aspects. The Neuroradiology Journal 30 (1) WMH on FLAIR are supposed to reflect the initial leukodystrophic aspect of VWM pathology characterized mainly by vacuolization of oligodendrocytic cell bodies and myelin abnormalities. 17, 18 In the final stage, atrophic areas of cavitations with myelin and axonal loss become evident by cystic degeneration. We propose that the initial leukodystrophic process, reflected by WMH, might be partially compensated in the initial state and is therefore more difficult to detect clinically. Thus, our findings challenge the proposed distinction of different forms of VWM that might well alternatively be explained by the functional significance of the individual distribution pattern of WMH. However, longitudinal WMH segmentation in VWM should ideally include white-matter volumetry and an estimation of cystic degeneration to monitor the parenchymal loss, which was not conducted in our study. Fourth, although control MS patients were included with clinical and radiographic features as similar as possible to the VWM patient (clinically stable, high lesion load, no change in visual exploration, followup within one year), we noticed that the EVD-based segmentation tended to overestimate WMH in the MS control group; however, this overestimation was consistent during follow-up.
In conclusion, this longitudinal study of a patient with adult-onset VWM shows that the recently proposed method of EVD-based WMH segmentation in the context of intensity histogram processing could be a powerful tool to rapidly, reliably and accurately quantify radiographic white-matter changes in an automated manner. This tool might therefore be beneficial to monitor the leukodystrophy in the course of VWM and related diseases with extensive WMH.
